2-(4-tert-butylbenzylamino)-ethanol | 945717-12-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-tert-butylbenzylamino)-ethanol
• 英文别名: 2-[(4-tert-butylphenyl)methylamino]ethanol
• CAS: 945717-12-4
• 化学式: C₁₃H₂₁NO
• mdl: MFCD11175347
• 分子量: 207.316
• InChiKey: WSBHHYVKQLETKW-UHFFFAOYSA-N

物化性质

• 沸点：
  330.5±22.0 °C(Predicted)
• 密度：
  0.978±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(4-tert-butylbenzylamino)-ethanol 在 sodium hydroxide 、 三乙胺 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 生成 3-(4-(2-((4-Tert-butylbenzyl)(benzo[d]thiazol-2-yl)amino)ethoxy)phenyl)propanoic acid
  参考文献：
  名称：

  Phenylpropanoic acid derivatives bearing a benzothiazole ring as PPARδ-selective agonists

  摘要：

  To find novel PPAR delta-selective agonists, we designed and synthesized phenylpropanoic acid derivatives bearing 6-substituted benzothiazoles. Optimization of this series led to the identification of a potent and selective PPAR delta agonist 17. Molecular modeling suggested that compound 17 occupies the Y-shaped pocket of PPAR6 appropriately. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.017
• 作为产物：
  描述：

  4-叔-丁基苄胺 在 4-二甲氨基吡啶 、 lithium aluminium tetrahydride 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 四氢呋喃 为溶剂， 生成 2-(4-tert-butylbenzylamino)-ethanol
  参考文献：
  名称：

  Phenylpropanoic acid derivatives bearing a benzothiazole ring as PPARδ-selective agonists

  摘要：

  To find novel PPAR delta-selective agonists, we designed and synthesized phenylpropanoic acid derivatives bearing 6-substituted benzothiazoles. Optimization of this series led to the identification of a potent and selective PPAR delta agonist 17. Molecular modeling suggested that compound 17 occupies the Y-shaped pocket of PPAR6 appropriately. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.017

文献信息

• Indole, indazole and indoline derivatives as CETP inhibitors
  申请人：Conte-Mayweg Aurelia

  公开号：US20060030613A1

  公开（公告）日：2006-02-09

  The present invention relates to compounds of formula (I): wherein —X—Y—, R 1 to R 11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.

  本发明涉及以下式(I)的化合物： 其中-X-Y-, R1至R11和n如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物对于治疗和/或预防通过CETP抑制剂介导的疾病是有用的。
• Heteroaryl and benzyl amide compounds
  申请人：Conte Aurelia

  公开号：US20070185058A1

  公开（公告）日：2007-08-09

  Compounds of formula I wherein R 1 , R 2 , R 4 , R 5 , A, B, D and n are as defined, and pharmaceutically acceptable salts thereof, processes for their preparation, their use as pharmaceuticals and pharmaceutical compositions comprising them.

  式I中的化合物，其中R1、R2、R4、R5、A、B、D和n的定义如上，并其药用盐，其制备方法，它们作为药物的用途以及包含它们的药物组合物。
• [EN] INDOLE, INDAZOLE OR INDOLINE DERIVATIVES<br/>[FR] DERIVES D'INDOLE, D'INDAZOLE OU D'INDOLINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2006013048A1

  公开（公告）日：2006-02-09

  The present invention relates to compounds of formula (I), wherein -X-Y-, Rl to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.

  本发明涉及式（I）化合物，其中-X-Y-，R1至R11和n如描述和权利要求所定义，并且其药学上可接受的盐。该化合物对于治疗和/或预防由CETP抑制剂介导的疾病是有用的。
• Anthranilamide and 2-amino-heteroarene-carboxamide compounds
  申请人：Conte Aurelia

  公开号：US20070219261A1

  公开（公告）日：2007-09-20

  Compounds of formula I processes for their preparation, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

  化学式为I的化合物，制备它们的方法，它们作为药物的用途以及包含它们的药物组合物。
• INDOLE, INDAZOLE OR INDOLINE DERIVATIVES
  申请人：F. Hoffmann-Roche AG

  公开号：EP1776338A1

  公开（公告）日：2007-04-25